This MedLibrary.org supplementary page on SIGLEC is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
SIGLECs, short for sialic acid binding Ig-like lectins are cell surface receptors and members of the immunoglobulin superfamily (IgSF) that recognize sugars. Their ability to recognize carbohydrates using an immunoglobulin domain places them in the group of I-type (Ig-type) lectins. They are transmembrane proteins that contain an N-terminal V-like immunoglobulin (IgV) domain that binds sialic acid and a variable number of C2-type Ig (IgC2) domains. 12
The first described Siglec is sialoadhesin (Siglec-1/CD169) that is a lectin-like adhesion molecule on macrophages.3 Other Siglecs were later added to this family, including CD22 (Siglec-2), which is restricted to B cells and has an important role in regulating their adhesion and activation,4 CD33 (Siglec-3) and myelin-associated glycoprotein (MAG/Siglec-4).5 Several additional Siglecs (Siglecs 5–12) have been identified in humans that are highly similar in structure to CD33 so are collectively referred to as ‘CD33-related Siglecs’.67 CD33-related siglecs all have two conserved immunoreceptor tyrosine-based inhibitory motif (ITIM)-like motifs in their cytoplasmic tails suggesting their involvement in cellular activation. 5
References
- ^ Crocker P, Clark E, Filbin M, Gordon S, Jones Y, Kehrl J, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar R, Sgroi D, Stamenkovic K, Schauer R, Schachner M, van den Berg T, van der Merwe P, Watt S, Varki A (1998). "Siglecs: a family of sialic-acid binding lectins". Glycobiology 8 (2): v. PMID 9498912.
- ^ Siglecs
- ^ Crocker P, Gordon S (1986). "Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages". J Exp Med 164 (6): 1862–75. doi:. PMID 3783087.
- ^ Stamenkovic I, Seed B (1990). "The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion". Nature 345 (6270): 74–7. doi:. PMID 1691828.
- ^ a b Crocker P, Varki A (2001). "Siglecs in the immune system". Immunology 103 (2): 137–45. doi:. PMID 11412300.
- ^ Foussias G, Taylor S, Yousef G, Tropak M, Ordon M, Diamandis E (2001). "Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs". Biochem Biophys Res Commun 284 (4): 887–99. doi:. PMID 11409877.
- ^ Angata T, Kerr S, Greaves D, Varki N, Crocker P, Varki A (2002). "Cloning and characterization of human Siglec-11. A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia". J Biol Chem 277 (27): 24466–74. doi:. PMID 11986327.
|
|||||||||||
 |
This protein-related article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 7 June 2008, at 15:43.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "SIGLEC".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.